These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 300626)

  • 61. Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice.
    Lee SW; Park KH; Park S; Kim JH; Hong SY; Lee SK; Choi D; Park YB
    Arthritis Rheum; 2013 Jul; 65(7):1902-12. PubMed ID: 23553192
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protein-G binding material from synovial fluid of rheumatoid arthritis patients induces unorthodox autoantibodies (IgG1 rheumatoid factor) in NZB, NZW and (NZB x NZW)F1 mice.
    Abedi-Valugerdi M; Ridderstad A; Lettesjö H; Ström H; Möller E
    Eur J Immunol; 1994 Mar; 24(3):684-91. PubMed ID: 8125137
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Isoprinosine delays the early appearance of autoimmunity in NZB/NZW F1 mice treated with interferon.
    Sergiescu D; Cerutti I; Kahan A; Piatier D; Efthymiou E
    Clin Exp Immunol; 1981 Jan; 43(1):36-45. PubMed ID: 6166417
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.
    Wofsy D; Seaman WE
    J Exp Med; 1985 Feb; 161(2):378-91. PubMed ID: 3919141
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA.
    Gilkeson GS; Ruiz P; Pippen AM; Alexander AL; Lefkowith JB; Pisetsky DS
    J Exp Med; 1996 Apr; 183(4):1389-97. PubMed ID: 8666897
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel susceptibility locus on chromosome 2 in the (New Zealand Black x New Zealand White)F1 hybrid mouse model of systemic lupus erythematosus.
    Rahman ZS; Tin SK; Buenaventura PN; Ho CH; Yap EP; Yong RY; Koh DR
    J Immunol; 2002 Mar; 168(6):3042-9. PubMed ID: 11884477
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.
    Szalai AJ; Weaver CT; McCrory MA; van Ginkel FW; Reiman RM; Kearney JF; Marion TN; Volanakis JE
    Arthritis Rheum; 2003 Jun; 48(6):1602-11. PubMed ID: 12794828
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation.
    Kozono Y; Kotzin BL; Holers VM
    J Immunol; 1996 Jun; 156(11):4498-503. PubMed ID: 8666826
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZB X NZW)F1 mice.
    Hirose S; Nagasawa R; Sekikawa I; Hamaoki M; Ishida Y; Sato H; Shirai T
    J Exp Med; 1983 Jul; 158(1):228-33. PubMed ID: 6864161
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA.
    Gilkeson GS; Pippen AM; Pisetsky DS
    J Clin Invest; 1995 Mar; 95(3):1398-402. PubMed ID: 7883986
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
    Drake CG; Rozzo SJ; Hirschfeld HF; Smarnworawong NP; Palmer E; Kotzin BL
    J Immunol; 1995 Mar; 154(5):2441-7. PubMed ID: 7868910
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 1-Methylisatin 3-thiosemicarbazone treatment of NZB x NZW hybrid mice.
    Gabriel R
    Br J Exp Pathol; 1971 Jun; 52(3):271-5. PubMed ID: 5314564
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The mechanism of action of cyclophosphamide on the nephritis of (NZB x NZW)F1 hybrid mice.
    Hurd ER; Ziff M
    Clin Exp Immunol; 1977 Jul; 29(1):132-9. PubMed ID: 302170
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Correlations of autoimmunity with H-2 and T cell receptor beta chain genotypes in (NZB X NZW) F2 mice.
    Noonan DJ; McConahey PJ; Cardenas GJ
    Eur J Immunol; 1990 May; 20(5):1105-10. PubMed ID: 1972678
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice.
    Gioud M; Kotzin BL; Rubin RL; Joslin FG; Tan EM
    J Immunol; 1983 Jul; 131(1):269-74. PubMed ID: 6863918
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ability of NZW but not NZB antigen-presenting cells to support T cell proliferative response to DNA methylated albumin.
    Papoian R; Talal N
    J Immunol; 1980 Feb; 124(2):515-9. PubMed ID: 6965382
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.
    Rudofsky UH; Dilwith RL; Roths JB; Lawrence DA; Kelley VE; Magro AM
    Am J Pathol; 1984 Jul; 116(1):107-14. PubMed ID: 6377906
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB X NZW)F1 hybrid.
    Sekigawa I; Ishida Y; Hirose S; Sato H; Shirai T
    J Immunol; 1986 Feb; 136(4):1247-52. PubMed ID: 3484766
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of transgenic mixed-haplotype MHC class II molecules A alpha d A beta z on autoimmune disease in New Zealand mice.
    Nishimura H; Ishikawa S; Nozawa S; Awaji M; Saito J; Abe M; Tokushima M; Kimoto M; Akakura S; Tsurui H; Hirose S; Shirai T
    Int Immunol; 1996 Jun; 8(6):967-76. PubMed ID: 8671686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.